Diamond Education Foundation The Shifting Migraine Paradigm 2024

Include: 37 videos + 37 audios + 37 file sub vtt + 37 pdfs, size: 17.08 GB

Target Audience: neurologists, headache specialists, primary care physicians 

Information:

This three-day conference, held in San Antonio, Texas, focused on the evolving landscape of headache medicine early in the year. The course addressed the “shifting paradigm” of migraine care, specifically re-evaluating long-standing beliefs about medication safety and efficacy. It offered a critical look at the comparative safety profiles of traditional therapies (like triptans) versus newer agents (CGRP inhibitors) and provided updates on integrative approaches, including the use of supplements and medical foods.

What You Will Learn

Attendees were able to:

• Re-evaluate the cardiovascular safety profile of triptans compared to CGRP monoclonal antibodies, challenging previous assumptions about risk.

• Integrate medical foods and evidence-based supplements into standard migraine treatment protocols.

• Update management strategies for complex headache disorders using the latest clinical data available at the start of 2024.

• Discuss the practical application of new therapeutics in a smaller, focused setting designed for direct interaction with faculty.

• Network with peers to share “in-the-trenches” strategies for managing insurance barriers and patient expectations.

Event Details

• Date: February 15 – 17, 2024

• Location: Plaza San Antonio Hotel & Spa, San Antonio, Texas

• Organizer: Diamond Headache Clinic Research & Educational Foundation

Who Should Attend

The course was designed for the interdisciplinary headache care team:

• Neurologists

• Primary Care Physicians (Family Practice, Internal Medicine)

• Nurse Practitioners (NPs) and Physician Assistants (PAs)

• Nurses

• Pharmacists

Why Attend

• Focused Curriculum: Unlike broader neurology conferences, this event provided a concentrated review of specific “paradigm shifts” in safety and efficacy that directly impact prescribing habits.

• Intimate Venue: The Plaza San Antonio offered a setting conducive to networking and one-on-one discussions with key opinion leaders in headache medicine.

• Integrative Focus: The inclusion of topics like “Supplements and Medical Foods” addressed the growing patient demand for holistic and non-pharmaceutical options alongside standard medical treatments.

Topics:

• When Dizzy is Actually a Migraine
• Trigeminal Autonomic Cephalalgias (TACs) and Facial Neuralgias
• Tension-Type and Cervicogenic Headache Disorders
• Optimization of Diagnosis and Treatment
• Migraine and Dementia – 2024 Updates
• Intractable Headache & Difficult Management Issues
• Rare Primary Headache Disorders – We are in the Weeds of the ICHD 3
• Multidisciplinary Approach to Intractable Headache Patients – 2024 Updates
• Post-Traumatic Headache – Concussion & Post Concussion in Children
• Indomethacin Responsive Headache Syndromes – 2024 Updates
• How to Deal with Special Patients – Pearls for Success – 2024 Updates
• Migraine Management 2017 vs. 2024 – Patient Dialogue Today
• CGRP & the New Treatment Paradigm
• Spontaneous Intracranial Hypotension (SIH) – A Recent Case
• Layering Therapies – What Do We Know
• Disparities in Migraine Care – 2024 Updates
• Diagnosis and Management – Pediatric Migraine
• Headache/Migraine in Pregnancy & Lactation
• Menstrual Migraine
• Perimenopause, Menopause & Migraine
• New Patient Appointments in The Headache Clinic – How to Begin
• Migraine Stigma
• Chronic Analgesics, Comorbid Pain Disorders, and Medication Overuse Headache
• Thunderclap Headache
• Management of the Difficult Cluster Headache Patients – 2024 Update
• Neuroimaging of Secondary Headaches and Red Flags
• Supplements and Medical Food for Headaches
• Devices and Blocks for Headache
• Inpatient Headache Treatment – 2024 Update
• A Case-Based Approach to Understanding CSF Pressure Disorders
• Unraveling the Connection Between Migraine and Autonomic Dysfunction
• Finding Fistulas
• Medication Overuse Headache – July 2025
• PACAP and Amylin in Migraine
• Unmasking the Myths of Idiopathic Intracranial Hypertension
• Sinus Headache – A Case
• Facial Neuralgias & Trigeminal Autonomic Cephalalgias